opendata.bot
Company number
10753026

NERRE THERAPEUTICS HOLDINGS LIMITED

InLiquidation
✓ Status: Liquidation. Next accounts due 31 March 2027.

Company details

East of England, England Contains OS data © Crown copyright and database right. Contains Royal Mail data © Royal Mail copyright and database right. Source: Office for National Statistics licensed under the Open Government Licence v.3.0.
Registered name
NERRE THERAPEUTICS HOLDINGS LIMITED
Company number
10753026
Registered office
SALISBURY HOUSE 2-3, SALISBURY VILLAS, CAMBRIDGE, CAMBRIDGESHIRE, CB1 2LA · 457 other companies at this postcode
Company type
Private Limited Company
Incorporated on
3 May 2017
Status
InLiquidation
Age
9 years
Nature of business (SIC)
72110 — Research and experimental development on biotechnology
Accounts — next due
31 Mar 2027
Accounts — last made up to
30 Jun 2025
Confirmation statement — next due
12 Mar 2027
Confirmation statement — last
26 Feb 2026

What the register says

Facts from the register, with the dates they are filed under. Not a score: what they mean is for you to judge, and every line can be checked against Companies House itself.

Companies House register snapshot, read 02/09/2026.

People with significant control

Beneficial owners holding over 25% of shares, voting rights or the right to appoint directors

Advent Life Sciences Llp
owns 25–50% of shares · holds 25–50% of voting rights
Notified 08/09/2017
Dr Michael Keith Trower
owns 75–100% of shares · holds 75–100% of voting rights · can appoint and remove directors
Notified 03/05/2017

Corporate structure

Who controls this company, and who they control in turn

2 controllers Drag to move · scroll to zoom · double-click to expand
Company Person Current control Ended

Connections

Corporate owner owns 25–50% of shares · holds 25–50% of votes Control ended 25/06/2021 Controls 30 companies
Dr Michael Keith Trower
born 11/1958 · United Kingdom owns 75–100% of shares · holds 75–100% of votes · can appoint and remove directors Control ended 08/09/2017 Controls 2 companies

Change history

Reconstructed from the dated records Companies House publishes

DateChangeWasNow
25/06/2021 Person with significant control ceased Advent Life Sciences Llp
08/09/2017 Person with significant control ceased Dr Michael Keith Trower
08/09/2017 Person with significant control added Advent Life Sciences Llp
03/05/2017 Person with significant control added Dr Michael Keith Trower

Documents for NERRE THERAPEUTICS HOLDINGS LIMITED

Need this one company on file? Buy the document on its own — no plan required.

Company extract£1.99

The full registration record as held today — name, number, status, registered office, company type, previous names, officers, PSC and SIC codes, timestamped for your file.

PDF Order
Financial statements£3.99

Every figure the company’s own accounts state, across each filed period, with year-on-year movement. Most UK companies file small or micro-entity accounts — a balance sheet and a headcount, no turnover or profit.

PDF + CSV Order
Ownership report£3.99

Who controls the company: persons with significant control, the nature of that control, the ownership graph and every other company those controllers hold.

PDF Order

Data protection register

No entry found on the ICO register of fee payers under this name.

Not every organisation has to register — some are exempt. An absent entry is a question to ask, not a finding.

Get this company via API

Every field on this page is available as structured JSON behind one endpoint and one API key.

GET /v1/company/gb/10753026
X-Api-Key: $OPENDATA_KEY
Read the API docs

Frequently asked questions

What is the company number of NERRE THERAPEUTICS HOLDINGS LIMITED?
According to the official registry, the company number of NERRE THERAPEUTICS HOLDINGS LIMITED is 10753026.
Where is NERRE THERAPEUTICS HOLDINGS LIMITED registered?
The registered office is SALISBURY HOUSE 2-3, SALISBURY VILLAS, CAMBRIDGE, CAMBRIDGESHIRE, CB1 2LA.
What is the SIC code of NERRE THERAPEUTICS HOLDINGS LIMITED?
The nature of business is recorded under SIC code 72110 — Research and experimental development on biotechnology.
Who controls NERRE THERAPEUTICS HOLDINGS LIMITED?
Advent Life Sciences Llp is recorded as a person with significant control, and owns 25–50% of shares, holds 25–50% of voting rights.
When are the next accounts of NERRE THERAPEUTICS HOLDINGS LIMITED due?
The next annual accounts are due by 31 March 2027, and the last accounts were made up to 30 June 2025.

About NERRE THERAPEUTICS HOLDINGS LIMITED (10753026)

NERRE THERAPEUTICS HOLDINGS LIMITED is a private limited company incorporated on 3 May 2017 and registered in the United Kingdom under company number 10753026. Its registered office is at SALISBURY HOUSE 2-3, SALISBURY VILLAS, CAMBRIDGE, CAMBRIDGESHIRE, CB1 2LA. The recorded nature of business is research and experimental development on biotechnology (SIC 72110). The company is currently inliquidation , with statutory accounts last made up to 30 June 2025. , and the person with significant control is Advent Life Sciences Llp. This profile is provided by opendata.bot by Noetikos, aggregating official data from Companies House bulk data , last refreshed 2 September 2026.

Companies at the same registered office

Research and experimental development on biotechnology across UK registers

The same sector and the same company, seen through every register we hold

Explore by sector

Every UK company records what it does as a SIC code — browse the sectors around this one.